BB 025
Alternative Names: BB-025; DTRI-025Latest Information Update: 19 Feb 2023
At a glance
- Originator Basking Biosciences
- Class Antifibrinolytics; Oligonucleotides; Vascular disorder therapies
- Mechanism of Action Blood coagulation modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Blood coagulation disorders